SAC StudioOversized dose, weak ratio, bad value
NaturesPlus's dose runs far hotter than we first reported: the label prints 1000 mg of Rhodiola root per tablet, not 250 mg — well above the 200-400 mg trial window — and NaturesPlus states no extract ratio, so it isn't confirmed as equivalent to the concentrated extract the trials used (we originally listed 250 mg; corrected 7 Sep 2026). It does guarantee 2.3% total rosavins and 0.5% salidroside, BELOW the 3%/1% SHR-5 profile the fatigue trials used (we originally repeated the 3/1 figure; the bottle does not back it — corrected 27 Aug 2026). Add the bilayer 'extended release' with no rhodiola-specific evidence and ~$17 for 30 tablets, and the value math stays among the worst here.
The label guarantees 2.3% total rosavins and 0.5% salidroside — real standardization, but roughly a quarter to a half below the 3%/1% SHR-5 profile the trials used. Products that guarantee the full studied ratio (Life Extension, NOW) outrank it on this axis.
The label prints 1000 mg of Rhodiola root per tablet — well above the 200-400 mg window the SHR-5 fatigue trials used — and NaturesPlus states no extract ratio, so this can't be confirmed as equivalent to the concentrated extract those trials tested. The tablet does clearly quantify 23 mg rosavins and 5 mg salidroside, but the total printed dose is a mismatch with the studied range, not a match.
cGMP, hypoallergenic and vegetarian, but little in the way of published third-party testing or COA transparency relative to NOW or Thorne.
A bilayer extended-release tablet. The extended-release delivery is not something the trials used or validated — there is no rhodiola-specific evidence it beats a standard capsule, and you pay a premium for it.
Only 30 tablets at ~$17 makes this among the most expensive per day on the list. The extended-release premium buys a benefit that isn't evidenced for rhodiola.
“Extended-release delivery improves rhodiola's effect”
The classic fatigue trials used standard extract capsules, not extended-release tablets. There is no rhodiola-specific evidence that a timed-release format outperforms a normal cap (Darbinyan 2000, PMID 11081987).
“The printed dose falls within the clinically studied 200-400 mg range”
The label prints 1000 mg of Rhodiola root per tablet — well above the 200-400 mg range used across the SHR-5 fatigue trials — and states no extract ratio, so it isn't confirmed as equivalent to the concentrated extract those trials tested (Olsson 2009, PMID 19016404).
An earlier version of this review said this tablet delivers 250 mg of Rhodiola extract, inside the 200-400 mg trial window. The Supplement Facts panel reads 1,000 mg Rhodiola (Rhodiola rosea root) per tablet, standardized to 23 mg rosavins (2.3%) and 5 mg salidroside (0.5%) — well above that window, with no extract ratio stated. We re-read the label on Sep 7, 2026 and corrected the dose figure throughout this review, including the Dose vs Clinical Range score.
The label's 1000 mg per tablet is well above the 200-400 mg trial window, with no extract ratio disclosed, and NaturesPlus wraps it in a costlier extended-release format and a 30-count bottle — so you pay a premium for a dose that isn't confirmed to match what the trials actually tested.
Timed-release can matter for some drugs, but rhodiola's trials never tested it. Absent that evidence, the format is a marketing differentiator, not a reason to pay a premium.
The label's 1000 mg per tablet runs well past the 200-400 mg trial window, with no extract ratio to confirm it's comparable to the trials' concentrated extract, and the 2.3%/0.5% ratio sits below the 3%/1% SHR-5 profile those trials used. Life Extension delivers a plainly-dosed 250 mg tablet at the studied ratio for roughly half the cost-per-day, without the unproven extended-release format.
Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.
A plainly-dosed 250 mg tablet at the full 3%/1% studied ratio, for far lower cost-per-day, without paying for an unevidenced release format.
See it on the list →If you want dose control and top-tier testing instead of a delivery gimmick, Thorne's 100 mg titratable caps are the better spend.
See it on the list →Standard (non-timed-release) SHR-5 capsules reduced stress fatigue, the format the evidence base actually rests on.
Effective doses fell in the low-hundreds of mg — well below this product's printed 1000 mg per tablet.
